home news forum careers events suppliers solutions markets expos directories catalogs resources advertise contacts
 
News Page

The news
and
beyond the news
Index of news sources
All Africa Asia/Pacific Europe Latin America Middle East North America
  Topics
  Species
Archives
News archive 1997-2008
 

Valent U.S.A. receives U.S. EPA approval for liquid formulation Fierce MTZ herbicide - Three effective modes of action provide stand-alone, long-lasting control


Walnut Creek, California, USA
January 15, 2019

Valent U.S.A. LLC today announced the launch of Fierce® MTZ Herbicide - a stand-alone liquid formulation that combines the company's leading herbicide, Fierce Herbicide, with the added benefit of metribuzin.  The company has received U.S. EPA approval, and first sales are expected in the 2019 growing season.

Fierce MTZ contains three effective modes of action that provide long lasting residual control of tough and resistant broadleaf weeds and annual grasses, including Palmer amaranth, common waterhemp, common and giant ragweed, and kochia.

Fierce MTZ protects fields for up to eight weeks and provides flexibility for crop rotation with limited carryover and rotational restrictions.  In addition, the liquid formulation provides easy mixing and loading.

"With weed control being a key hurdle year after year, we continue to recommend using multiple effective modes of action in weed management systems," said Dr. John Pawlak, Valent product development manager.  "Fierce MTZ provides the longest control over the largest spectrum of troublesome weeds than any other comparable product on the market."

For more information on Fierce MTZ, visit www.valent.com/fiercemtz or contact your local Valent sales representative. 



More news from: Sumitomo Biorational Company LLC (SBC)


Website: http://www.valent.com

Published: January 16, 2019

The news item on this page is copyright by the organization where it originated
Fair use notice

 
 
 
 
 
 
 
 
 
 
 
 

  Archive of the news section


Copyright @ 1992-2026 SeedQuest - All rights reserved